Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Richard Iorio

Adult Reconstructive Orthopaedic Surgery Burlington, MA Medical Doctor

NPI 1275631194 CMS profile 284321

41 Mall Rd, Lahey Clinic, Burlington, MA 01805

Open in the dashboard

General payments

$29,163

60 records reported · program years 2019–2025

Research payments

$7,275

Paid to them · 4 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Richard Iorio of Burlington, MA is reported in the CMS Open Payments database as having received $29,163 across 60 general payments and $7,275 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 73rd percentile of Adult Reconstructive Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,868 4
2024 General $1,898 2
2023 General $1,819 6
2023 Research $7,275 4
2022 General $9,828 5
2021 General $1,603 17
2020 General $1,470 9
2019 General $7,678 17

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Richard Iorio
  • Adult Reconstructive Orthopaedic Surgery median
  • Middle half of Adult Reconstructive Orthopaedic Surgery
  • National median

In program year 2025, general payments to Richard Iorio were reported at $4,868. Among 1,079 Adult Reconstructive Orthopaedic Surgery profiles paid that year, the median was $1,406 and the middle half received between $318 and $8,709.

Show as a table
Year Richard Iorio Adult Reconstructive Orthopaedic Surgery median Middle half National median
2019 $7,678 $1,416 $292–$9,336 $163
2020 $1,470 $647 $141–$6,474 $114
2021 $1,603 $1,073 $211–$6,497 $132
2022 $9,828 $1,217 $236–$6,299 $149
2023 $1,819 $1,082 $246–$6,818 $160
2024 $1,898 $1,575 $323–$8,944 $164
2025 $4,868 $1,406 $318–$8,709 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Aesculap Implant Systems, LLC $15,482 26 payments
  2. Regeneron Pharmaceuticals, Inc. $4,832 3 payments
  3. Pacira Pharmaceuticals Incorporated $3,613 6 payments
  4. Medical Device Business Services, Inc. $2,706 2 payments
  5. Stryker Corporation $1,280 15 payments
  6. Chugai Pharmaceutical Co., Ltd. $567 1 payment
  7. Conformis, Inc. $241 2 payments
  8. Innovation Technologies Inc $163 1 payment
  9. Becton, Dickinson and Company $130 1 payment
  10. Zimmer Biomet Holdings, Inc. $95 1 payment
  11. Other $53 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $23,123 10 payments
  2. Travel and Lodging $4,041 19 payments
  3. Food and Beverage $1,999 31 payments
Products named General payments · program years 2019–2025
  1. COREHIP PRIMARY $13,537 14 payments
  2. EXPAREL Pain Management $3,613 6 payments
  3. EXPAREL Spine $2,706 2 payments
  4. COREHIP SYSTEM $1,946 12 payments
  5. MAKO $1,002 11 payments
  6. Non-Covered Product $567 1 payment
  7. iTotal Identity PS $258 2 payments
  8. REUNION $175 1 payment
  9. Irrisept $163 1 payment
  10. Identity Imprint CR $129 1 payment
  11. Other $584 10 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Aesculap Implant Systems, LLC $7,275 4 payments

Billing to Medicare

Part B · data year 2024 · 13 billing codes

Paid by Medicare

$63,497

Of which drugs: $164

Medicare patients

259

Average age 74

Services billed

593

160 women, 99 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 74%
Depression 27%
Diabetes 26%
Ischemic heart disease 24%
Osteoporosis 22%
Atrial fibrillation 19%
Chronic kidney disease 19%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 30 214 $164

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

64 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Adult Reconstructive Orthopaedic Surgery in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record